Senators Question Health Secretary Kennedy on Gardasil Settlement Disclosures
MRK sits 95% above its 52-week low of $77.58.
Summary
Four Democratic senators sent a letter to Health Secretary Robert F. Kennedy Jr. questioning inconsistencies in his disclosures regarding a financial stake in litigation over Merck's Gardasil vaccine. Merck earlier this year agreed to pay $50 million to settle Gardasil litigation, and Kennedy, a former attorney in some cases, had initially said he would keep a 10% fee but later said he would transfer his interest to his son. Kennedy now says neither he nor his family received any money from the settlement, contradicting his earlier ethics filings. The senators are asking why he certified a transfer that apparently did not occur. This raises political and regulatory scrutiny around Gardasil, a key Merck product, and could influence vaccine policy and litigation risk.
At the time of this announcement, MRK was trading at $151.31 on NYSE in the Life Sciences sector, with a market capitalization of approximately $371.7B. The 52-week trading range was $77.58 to $154.49. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.